Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Status and Forecast 2021-2027

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ACH-4471
1.2.3 ALN-CC5
1.2.4 ALXN-1210
1.2.5 AMY-101
1.2.6 APL-2
1.2.7 Others
1.3 Market by Application
1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Perspective (2016-2027)
2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Growth Trends by Regions
2.2.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Industry Dynamic
2.3.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trends
2.3.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers
2.3.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Challenges
2.3.4 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Revenue
3.1.1 Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Revenue (2016-2021)
3.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
3.4 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Concentration Ratio
3.4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in 2020
3.5 Paroxysmal Nocturnal Hemoglobinuria Treatment Key Players Head office and Area Served
3.6 Key Players Paroxysmal Nocturnal Hemoglobinuria Treatment Product Solution and Service
3.7 Date of Enter into Paroxysmal Nocturnal Hemoglobinuria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paroxysmal Nocturnal Hemoglobinuria Treatment Breakdown Data by Type
4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Size by Type (2016-2021)
4.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Type (2022-2027)
5 Paroxysmal Nocturnal Hemoglobinuria Treatment Breakdown Data by Application
5.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Size by Application (2016-2021)
5.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2016-2027)
6.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
6.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021)
6.2.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027)
6.2.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2027)
6.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
6.3.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021)
6.3.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027)
6.3.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2027)
6.4 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
6.4.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021)
6.4.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2016-2027)
7.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
7.2.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021)
7.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027)
7.2.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2027)
7.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
7.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021)
7.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027)
7.3.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2027)
7.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
7.4.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021)
7.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2016-2027)
8.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
8.2.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
8.3.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region
8.4.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2016-2027)
9.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
9.2.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2027)
9.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
9.3.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2027)
9.4 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
9.4.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2016-2027)
10.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
10.2.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
10.3.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
10.4.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Achillion Pharmaceuticals Inc
11.1.1 Achillion Pharmaceuticals Inc Company Details
11.1.2 Achillion Pharmaceuticals Inc Business Overview
11.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.1.4 Achillion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.1.5 Achillion Pharmaceuticals Inc Recent Development
11.2 Akari Therapeutics Plc
11.2.1 Akari Therapeutics Plc Company Details
11.2.2 Akari Therapeutics Plc Business Overview
11.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.2.4 Akari Therapeutics Plc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.2.5 Akari Therapeutics Plc Recent Development
11.3 Alexion Pharmaceuticals Inc
11.3.1 Alexion Pharmaceuticals Inc Company Details
11.3.2 Alexion Pharmaceuticals Inc Business Overview
11.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.3.4 Alexion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.3.5 Alexion Pharmaceuticals Inc Recent Development
11.4 Alnylam Pharmaceuticals Inc
11.4.1 Alnylam Pharmaceuticals Inc Company Details
11.4.2 Alnylam Pharmaceuticals Inc Business Overview
11.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.4.4 Alnylam Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.4.5 Alnylam Pharmaceuticals Inc Recent Development
11.5 Amgen Inc
11.5.1 Amgen Inc Company Details
11.5.2 Amgen Inc Business Overview
11.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.5.4 Amgen Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.5.5 Amgen Inc Recent Development
11.6 Apellis Pharmaceuticals Inc
11.6.1 Apellis Pharmaceuticals Inc Company Details
11.6.2 Apellis Pharmaceuticals Inc Business Overview
11.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.6.4 Apellis Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.6.5 Apellis Pharmaceuticals Inc Recent Development
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd Recent Development
11.8 ISU ABXIS Co Ltd
11.8.1 ISU ABXIS Co Ltd Company Details
11.8.2 ISU ABXIS Co Ltd Business Overview
11.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.8.4 ISU ABXIS Co Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.8.5 ISU ABXIS Co Ltd Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.9.4 Novartis AG Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 NovelMed Therapeutics Inc
11.10.1 NovelMed Therapeutics Inc Company Details
11.10.2 NovelMed Therapeutics Inc Business Overview
11.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.10.4 NovelMed Therapeutics Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.10.5 NovelMed Therapeutics Inc Recent Development
11.11 Omeros Corp
11.11.1 Omeros Corp Company Details
11.11.2 Omeros Corp Business Overview
11.11.3 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.11.4 Omeros Corp Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.11.5 Omeros Corp Recent Development
11.12 Ra Pharmaceuticals Inc
11.12.1 Ra Pharmaceuticals Inc Company Details
11.12.2 Ra Pharmaceuticals Inc Business Overview
11.12.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.12.4 Ra Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.12.5 Ra Pharmaceuticals Inc Recent Development
11.13 Regeneron Pharmaceuticals Inc
11.13.1 Regeneron Pharmaceuticals Inc Company Details
11.13.2 Regeneron Pharmaceuticals Inc Business Overview
11.13.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.13.4 Regeneron Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.13.5 Regeneron Pharmaceuticals Inc Recent Development
11.14 Regenesance BV
11.14.1 Regenesance BV Company Details
11.14.2 Regenesance BV Business Overview
11.14.3 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.14.4 Regenesance BV Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021)
11.14.5 Regenesance BV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ACH-4471
Table 3. Key Players of ALN-CC5
Table 4. Key Players of ALXN-1210
Table 5. Key Players of AMY-101
Table 6. Key Players of APL-2
Table 7. Key Players of Others
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Regions (2016-2021)
Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Regions (2022-2027)
Table 14. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trends
Table 15. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers
Table 16. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Challenges
Table 17. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints
Table 18. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Players (2016-2021)
Table 20. Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment as of 2020)
Table 21. Ranking of Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Paroxysmal Nocturnal Hemoglobinuria Treatment Product Solution and Service
Table 25. Date of Enter into Paroxysmal Nocturnal Hemoglobinuria Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Achillion Pharmaceuticals Inc Company Details
Table 66. Achillion Pharmaceuticals Inc Business Overview
Table 67. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 68. Achillion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 69. Achillion Pharmaceuticals Inc Recent Development
Table 70. Akari Therapeutics Plc Company Details
Table 71. Akari Therapeutics Plc Business Overview
Table 72. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 73. Akari Therapeutics Plc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 74. Akari Therapeutics Plc Recent Development
Table 75. Alexion Pharmaceuticals Inc Company Details
Table 76. Alexion Pharmaceuticals Inc Business Overview
Table 77. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 78. Alexion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 79. Alexion Pharmaceuticals Inc Recent Development
Table 80. Alnylam Pharmaceuticals Inc Company Details
Table 81. Alnylam Pharmaceuticals Inc Business Overview
Table 82. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 83. Alnylam Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 84. Alnylam Pharmaceuticals Inc Recent Development
Table 85. Amgen Inc Company Details
Table 86. Amgen Inc Business Overview
Table 87. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 88. Amgen Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 89. Amgen Inc Recent Development
Table 90. Apellis Pharmaceuticals Inc Company Details
Table 91. Apellis Pharmaceuticals Inc Business Overview
Table 92. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 93. Apellis Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 94. Apellis Pharmaceuticals Inc Recent Development
Table 95. F. Hoffmann-La Roche Ltd Company Details
Table 96. F. Hoffmann-La Roche Ltd Business Overview
Table 97. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 98. F. Hoffmann-La Roche Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 99. F. Hoffmann-La Roche Ltd Recent Development
Table 100. ISU ABXIS Co Ltd Company Details
Table 101. ISU ABXIS Co Ltd Business Overview
Table 102. ISU ABXIS Co Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 103. ISU ABXIS Co Ltd Recent Development
Table 104. Novartis AG Company Details
Table 105. Novartis AG Business Overview
Table 106. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 107. Novartis AG Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 108. Novartis AG Recent Development
Table 109. NovelMed Therapeutics Inc Company Details
Table 110. NovelMed Therapeutics Inc Business Overview
Table 111. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 112. NovelMed Therapeutics Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 113. NovelMed Therapeutics Inc Recent Development
Table 114. Omeros Corp Company Details
Table 115. Omeros Corp Business Overview
Table 116. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 117. Omeros Corp Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 118. Omeros Corp Recent Development
Table 119. Ra Pharmaceuticals Inc Company Details
Table 120. Ra Pharmaceuticals Inc Business Overview
Table 121. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 122. Ra Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 123. Ra Pharmaceuticals Inc Recent Development
Table 124. Regeneron Pharmaceuticals Inc Company Details
Table 125. Regeneron Pharmaceuticals Inc Business Overview
Table 126. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 127. Regeneron Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 128. Regeneron Pharmaceuticals Inc Recent Development
Table 129. Regenesance BV Company Details
Table 130. Regenesance BV Business Overview
Table 131. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 132. Regenesance BV Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2016-2021) & (US$ Million)
Table 133. Regenesance BV Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type: 2020 VS 2027
Figure 2. ACH-4471 Features
Figure 3. ALN-CC5 Features
Figure 4. ALXN-1210 Features
Figure 5. AMY-101 Features
Figure 6. APL-2 Features
Figure 7. Others Features
Figure 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Paroxysmal Nocturnal Hemoglobinuria Treatment Report Years Considered
Figure 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Regions (2022-2027)
Figure 17. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Players in 2020
Figure 18. Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in 2020
Figure 20. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2016-2027)
Figure 24. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2016-2027)
Figure 25. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Country (2016-2027)
Figure 26. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2016-2027)
Figure 30. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2016-2027)
Figure 31. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Country (2016-2027)
Figure 32. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Paroxysmal Nocturnal Hemoglob

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs